Table 2.
Biochemical indicators of patients with ACI and with and without PSD
| Variables, mean(SD) | PSD (n = 36) | Non-PSD (n = 47) | P value |
|---|---|---|---|
| TT3, μg/L | 1.1(0.2) | 1.3(0.2) | < 0.001# |
| TT4, μg/L | 79.8(10.6) | 81.1(11.0) | 0.587 |
| TSH, uIU/mL | 1.6(0.9) | 1.5(0.7) | 0.629 |
| LDL, mmol/L | 2.5(0.9) | 2.6(0.9) | 0.622 |
| HDL, mmol/L | 1.2(0.3) | 1.2(0.4) | 0.549 |
| FBG, mmol/L | 6.8(2.2) | 6.3(2.0) | 0.338 |
| 2hPBG, mmol/L | 10.2(4.6) | 9.6(4.5) | 0.548 |
| HbAlc, % | 6.1(1.5) | 6.2(1.8) | 0.793 |
| NE, ng/L | 931.8(172.9) | 1237.8(296.5) | < 0.001# |
| DA, ng/L | 46.7(10.2) | 64.7(8.9) | < 0.001# |
| 5-HT, ng/L | 821.7(228.4) | 1065.9(144.3) | < 0.001# |
| IL-6, ng/L | 4.6(1.0) | 3.4(0.9) | < 0.001# |
| TNF-α, ng/L | 224.4(44.1) | 164.9(43.7) | < 0.001# |
| NGF, ng/L | 6.5(1.5) | 8.1(1.6) | < 0.001# |
| CGRP, pg/ml | 41.9(6.1) | 38.3(13.8) | 0.112 |
P values compare persons with and without PSD. # P < 0.001 vs non-PSD group
Data are displayed as mean (standard deviation)
CGRP calcitonin gene-related peptide, DA dopamine, FBG fasting blood glucose, 5-HT 5-hydroxytryptamine, HbA1c glycosylated hemoglobin, type A1c, HDL high-density lipoprotein, IL-6 interleukin 6, LDL low-density lipoprotein, NE norepinephrine, NGF nerve growth factor, 2hPBG 2-h postprandial blood glucose, PSD post-stroke depression, SD standard deviation, TNF-α tumor necrosis factor-α, TSH thyroid-stimulating hormone, TT3 total triiodothyronine, TT4 total thyroxine